These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19475464)

  • 21. Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner.
    Betzel B; Koehestanie P; Homan J; Aarts EO; Janssen IM; de Boer H; Wahab PJ; Groenen MJ; Berends FJ
    Gastrointest Endosc; 2017 Feb; 85(2):409-415. PubMed ID: 27451295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Duodenal-Jejunal Bypass Surgery on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial.
    Petry TZ; Fabbrini E; Otoch JP; Carmona MA; Caravatto PP; Salles JE; Sarian T; Correa JL; Schiavon CA; Patterson BW; Cohen R; Klein S
    Obesity (Silver Spring); 2015 Oct; 23(10):1973-9. PubMed ID: 26414562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.
    Muñoz R; Dominguez A; Muñoz F; Muñoz C; Slako M; Turiel D; Pimentel F; Sharp A; Escalona A
    Surg Endosc; 2014 Apr; 28(4):1056-62. PubMed ID: 24196558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.
    Betzel B; Cooiman MI; Aarts EO; Janssen IMC; Wahab PJ; Groenen MJM; Drenth JPH; Berends FJ
    Surg Endosc; 2020 Jan; 34(1):209-215. PubMed ID: 30877567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis.
    Ferzli GS; Dominique E; Ciaglia M; Bluth MH; Gonzalez A; Fingerhut A
    World J Surg; 2009 May; 33(5):972-9. PubMed ID: 19288284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect.
    Lee WJ; Chong K; Lin YH; Wei JH; Chen SC
    Obes Surg; 2014 Sep; 24(9):1552-62. PubMed ID: 24965545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.
    Blicklé JF; Hancu N; Piletic M; Profozic V; Shestakova M; Dain MP; Jacqueminet S; Grimaldi A
    Diabetes Obes Metab; 2009 Apr; 11(4):379-86. PubMed ID: 19087105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of glycaemia control in subjects with type 2 diabetes by self-monitoring of blood glucose: comparison of two management programs adjusting bedtime insulin dosage.
    Chen HS; Wu TE; Jap TS; Lin SH; Hsiao LC; Lin HD
    Diabetes Obes Metab; 2008 Jan; 10(1):34-40. PubMed ID: 18095948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-Year-Results of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Weight Loss and Type 2 Diabetes Mellitus.
    Seki Y; Kasama K; Haruta H; Watanabe A; Yokoyama R; Porciuncula JP; Umezawa A; Kurokawa Y
    Obes Surg; 2017 Mar; 27(3):795-801. PubMed ID: 27644433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial.
    Lee WJ; Chong K; Ser KH; Lee YC; Chen SC; Chen JC; Tsai MH; Chuang LM
    Arch Surg; 2011 Feb; 146(2):143-8. PubMed ID: 21339423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
    Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
    Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.
    Forner PM; Ramacciotti T; Farey JE; Lord RV
    Obes Surg; 2017 Dec; 27(12):3306-3313. PubMed ID: 29018990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliopancreatic diversion with duodenojejunal exclusion associated with truncal vagotomy: a new proposal for type 2 diabetes mellitus treatment.
    Alleotti E; Palma RT; Pinto Junior PE; Bento JA; Yonamine R; Campos AL; Waisberg J
    Acta Cir Bras; 2012 Aug; 27(8):577-84. PubMed ID: 22850711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 diabetes control in a nonobese rat model using sleeve gastrectomy with duodenal-jejunal bypass (SGDJB).
    Sun D; Liu S; Zhang G; Chen W; Yan Z; Hu S
    Obes Surg; 2012 Dec; 22(12):1865-73. PubMed ID: 22911149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Great Curvature Plication with Duodenal-Jejunal Bypass (GCP-DJB) and Sleeve Gastrectomy (SG) on Metabolic Indices and Gut Hormones in Type 2 Diabetes Mellitus Rats.
    Qiu NC; Li W; Liu ME; Cen XX; Shan CX; Zhang W; Liu Q; Wang Y; Zhu YT; Qiu M
    Obes Surg; 2018 Dec; 28(12):4014-4021. PubMed ID: 30109670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.
    de Moura EG; Martins BC; Lopes GS; Orso IR; de Oliveira SL; Galvão Neto MP; Santo MA; Sakai P; Ramos AC; Garrido Júnior AB; Mancini MC; Halpern A; Cecconello I
    Diabetes Technol Ther; 2012 Feb; 14(2):183-9. PubMed ID: 21932999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes.
    Colás A; Varela M; Mraz M; Novak D; Cuesta-Frau D; Vigil L; Benes M; Pelikanova T; Haluzik M; Burda V; Vargas B
    Diabetes Metab Res Rev; 2020 May; 36(4):e3287. PubMed ID: 31916665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2.
    Proczko-Markuszewska M; Stefaniak T; Kaska Ł; Sledziński Z
    Pol Przegl Chir; 2011 Feb; 83(2):81-6. PubMed ID: 22166285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year.
    Nocca D; Guillaume F; Noel P; Picot MC; Aggarwal R; El Kamel M; Schaub R; de Seguin de Hons C; Renard E; Fabre JM
    Obes Surg; 2011 Jun; 21(6):738-43. PubMed ID: 21468625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.